Armodafinil, > = 98% (HPLC)

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

Armodafinil may be used in cell signaling studies.

Biochem/physiol Actions

Armodafinil is a non-amphetamine, having a half-life of 10−14 hours.

Armodafinil has affinity for dopamine transporters and inhibits the uptake of dopamine in brain areas that are involved in the cognitive performances. It is beneficial for the patients of substance abuse and mental disorders.

Armodafinil is the R isomer and longer-lasting isomer of racemic modafinil. It is a psychostimulant wake-promoting agent developed for the treatment of narcolepsy, shift work sleep disorder and excessive daytime sleepiness associated with obstructive sleep apnea

Features and Benefits

This compound was developed by Teva. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.